Revance Therapeutics Inc (RVNC)

[Aestheticexec]

So here we are - analysts are resetting their models. It’s not a luxury DTC business. Strategy needs a full reset, company has been blowing cash, and something still doesn’t look right: $420 / vial (cute number btw - you can do that stuff when you’re Elon, but not a struggling medical company), 80% margins = ~$100/vial cogs?!!!? Try to square that with the huge gap in payer savings with one fewer treatment, and there’s so much therapeutic value left on the table. Package it all with passing comments about theoretical savings from the Nashville headquarters (which can not be real savings) and writing off the HintMD acquisition. Company expenses need to be cut to the bone, close Nashville and Newport offices, run aesthetics with 100 reps and four marketers. Shift headcount to therapeutic.